Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling

Grants

Funding Acknowledgements

This work was funded in part by grant support from the BONFOR research commission (University of Bonn, Germany) (to D.D.N.); National Institutes of Health Grant 1R01AR066808-01A1, the Excellence Cluster Immuno-Sensation, and German Research Foundation Grants TRR83, 57, and SFB1123 (to E. L.); and NHMRC Grants 1144282, 1142354, and 1099262, the Sylvia and Charles Viertel Foundation, and an HHMI-Wellcome International Research Scholarship (to S. L. M.). V. R. is a paid employee of Pfizer Inc. E. L. is a co-founder and consultant to IFM Therapeutics. S. L. M. is a consultant to GlaxoSmithKline. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.